$47.90
2.475.44%
Last update: Nov 6, 5:53 PM
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History
TRAXNASDAQ
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
You can purchase shares of First Tracks (NASDAQ:TRAX) through any online brokerage.
Other companies in First Tracks’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
First Tracks has a consensus price target of $71.18.
The stock price for First Tracks (NASDAQ: TRAX) is $49 last updated November 6, 2026 at 5:53 PM EST.
There are no upcoming dividends for First Tracks.
First Tracks does not have any upcoming earnings scheduled.
There is no upcoming split for First Tracks.
First Tracks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell...
